Successful intestinal transplantation in pigs treated with cyclosporine.
To date, it has not been possible to reliably prevent intestinal allograft rejection in large animals. This study was undertaken to determine if continuous i.v. cyclosporine (CsA) followed by p.o. CsA would prevent rejection in outbred piglets with orthotopic, in-continuity intestinal allografts. Untreated recipients (n = 7) died of rejection (2), interstitial pnuemontitis (3), or technical complications (2) at 5.3 +/- 1 days. Intestinal recipients treated with i.v. CsA 8 mg/kg/day and i.v. steroids (n = 3) died of rejection (mean survival 11.3 +/- 3.2 days). CsA 20 mg/kg/day i.v. plus i.v. steroids for 21 days, followed by p.o. CsA 25 mg/kg/day (n = 6) prevented rejection; however, most of the recipients developed fatal infections (mean survival 28 +/- 8 days). Intravenous CsA 15 mg/kg/day for 7-10 days (n = 16), followed by p.o. CsA 30 mg/kg/day in tapering doses reliably prevented graft rejection, permitting long-term survival (mean survival 121 +/- 32 days). Rejection did not occur in 7 animals when CsA was discontinued at 97 +/- 11 days. Seven animals surviving more than 100 days maintained normal nutritional indices and gained weight at the same rate as control animals. This study provides a rationale for further experimentation to determine the feasibility of intestinal transplantation in man.
D000206:Actuarial Analysis; D000818:Animals; D003524:Cyclosporins / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000187:drug effects; D007262:Infusions, Intravenous; D007421:Intestine, Small / Q000473:pathology / Q000502:physiology / Q000637:transplantation*; D007959:Lymphocyte Culture Test, Mixed; D011658:Pulmonary Fibrosis / Q000209:etiology / Q000473:pathology; D013552:Swine; D014184:Transplantation, Homologous / Q000009:adverse effects / Q000401:mortality
D003524:Cyclosporins